Podcasts about Novo

Convidado: Fernando Abrucio, cientista político, professor da FGV-EAESP e comentarista da GloboNews. Então candidato de oposição ao governo de Jair Bolsonaro (PL), Lula (PT) surpreendeu o mundo político ao anunciar o convite para que Geraldo Alckmin (PSB) fosse o vice-presidente na chapa que concorreria nas eleições de 2022. O ex-tucano e adversário histórico do PT topou, e a estratégia deu certo: a dobradinha Lula-Alckmin se apresentou ao eleitor como representante de uma frente ampla e venceu a eleição. Quatro anos depois, presidente e vice demonstram ter excelente relação e trocam elogios em público, mas nada garante que a parceria irá se repetir na urna. Lula dá sinais de que a vaga está aberta para negociações com partidos de centro, como o MDB. O objetivo é ampliar alianças, conquistar mais palanques estaduais e municipais e aumentar o tempo de propaganda eleitoral. Na oposição, a pré-candidatura de Flávio Bolsonaro se consolida como a mais competitiva, de acordo com as pesquisas mais recentes. E já circulam especulações de potenciais candidatos a vice. Os mais citados são Romeu Zema, governador de Minas Gerais, do Novo, e Tereza Cristina, senadora pelo Mato Grosso do Sul, do PP. Para analisar a viabilidade de todas as estratégias eleitorais em jogo, Natuza Nery recebe o cientista político Fernando Abrucio. Ele, que é professor da FGV-EAESP e comentarista da GloboNews, comenta a situação de Geraldo Alckmin no governo e o que Lula busca nas conversas com partidos de centro; e avalia os nomes em torno de Flávio Bolsonaro.

Novo estudo revela profundas desigualdades no acesso ao tratamento, sobretudo em países africanos e entre mulheres; cobertura da cirurgia deverá subir cerca de 8,4% nesta década; ritmo atual não chega para cumprir as metas globais até 2030.

No podcast ‘Notícia No Seu Tempo’, confira em áudio as principais notícias da edição impressa do jornal ‘O Estado de S.Paulo’ desta terça-feira (17/02/2026): No dia seguinte ao desfile da escola de samba Acadêmicos de Niterói, cujo enredo foi a vida do presidente Luiz Inácio Lula da Silva (PT), o senador Flávio Bolsonaro (PL-RJ), pré-candidato à Presidência, afirmou que vai protocolar ação no Tribunal Superior Eleitoral contra supostos crimes cometidos pelo PT na Marquês de Sapucaí. O partido Novo também informou que vai apresentar ação contra o desfile, pedindo a inelegibilidade de Lula. A alegação é de que houve propaganda antecipada financiada com dinheiro público. A Embratur, estatal vinculada ao governo federal, contribui com o financiamento de todas as escolas de samba do Rio de Janeiro, assim com a Prefeitura e o governo do Estado. Especialistas ouvidos pelo Estadão se dividem na análise do episódio. Há quem fale em “zona de penumbra”, em falta de respaldo jurídico e em procedência da ação. E mais: Economia: IPCA mais perto de 3% em março vira trunfo eleitoral Internacional: Em visita à Índia e à Coreia do Sul, Lula busca acordos em setores estratégicos Metrópole: Rodovias federais têm 199 acidentes e 16 óbitos por dia Cultura: Bonecões de Olinda surgem em versão ‘O Agente Secreto’ See omnystudio.com/listener for privacy information.

O partido Novo informou que deve pedir a inelegibilidade do presidente Luiz Inácio Lula da Silva (PT) por suposto abuso de poder político e econômico. O PL planeja solicitar ao TSE (Tribunal Superior Eleitoral) para que abra as contas da Acadêmicos de Niterói. O objetivo é saber se empresários com contratos com o governo federal financiaram a escola e o desfile a pedido do Palácio do Planalto. Em outra frente, deputados da oposição acionaram a PGR (Procuradoria-Geral da República) contra a agremiação por retratar evangélicos em fantasias de “latas de conserva”. Para os parlamentares, a manifestação configura discriminação religiosa. O diretor de jornalismo da CNN em Brasília, Daniel Rittner, e Tailaine Cristina Costa, especialista em Direito Eleitoral, debatem o tema. 

Neste episódio especial, Yuri Moraes e Roberto Sadovski revelam a Lista Definitiva dos Melhores Filmes de 2025. Analisamos os lançamentos mais aguardados e polêmicos do ano, desde o novo Superman de James Gunn até o documentário sem filtros de Kanye West (In Whose Name) e o retorno de Danny Boyle com a franquia Extermínio.Além das críticas de cinema, fazemos o anúncio oficial da nossa estreia no UOL com o programa Enquadrado. Contamos os bastidores da nova parceria, a saída de projetos anteriores e debatemos diretores divisivos como Lars Von Trier, Spielberg e Kleber Mendonça Filho com seu novo "O Agente Secreto".Se você busca indicações de filmes cult, blockbusters inteligentes e uma conversa honesta sobre a indústria cinematográfica, essa live é o guia essencial para o seu ano.

OIM afirma que milhares de pessoas que retornaram ao país ainda estão deslocadas e podem fugir novamente; temperaturas congelantes do inverno estão se tornando insuportáveis devido à escassez cada vez mais grave de eletricidade e aquecimento.

Nos encontre no Instagram: https://www.instagram.com/novachurchatlanta/

Ministração realizada no dia 15 de fevereiro de 2026.

Investorer bør kigge mod Japan lige nu. Der sker ting, der kan have stor betydning for markeder og den globale økonomi. Vi skal også til OL. For hvad koster et vinter-OL egentlig? Hvor mange sponsorpenge er der på spil? Og hvilke atleters lønseddel er i den helt dyre ende? Vi dykker ned i tallene bag De Olympiske Lege i sneen. Til sidst tager vi lige temperaturen på kopikampen for Novo Nordisk. Vært: Ulrik Rosenkvist Schultz. Fast gæst: Sune Aagaard. Medvirkende: Josefine Høgh, vært hos DR og Josephine Cetti, chefstrateg hos Nordea.

Confira os destaques de Os Pingos nos Is desta sexta-feira (13):O ministro do STF Dias Toffoli é alvo de dez pedidos de impeachment apresentados no Senado, sendo que três requerimentos citam o caso do Banco Master como principal motivação. A abertura do processo depende de decisão do presidente da Casa e, embora prevista na Constituição, nunca foi aplicada no Brasil. Novo relator do caso Banco Master no STF, o ministro André Mendonça se reuniu com delegados da Polícia Federal para entender o estágio das investigações e alinhar procedimentos. Após assumir a relatoria por sorteio, ele deve analisar pedidos de parlamentares e avaliar a possibilidade de levantamento do sigilo do processo, que foi imposto anteriormente na Corte. Uma sessão reservada do STF sobre a relatoria do caso Banco Master teve forte tom político e discussão interna entre os ministros. Após divergências, Dias Toffoli deixou a condução do processo, que foi redistribuído a André Mendonça. A divulgação de diálogos da reunião gerou suspeitas de gravação clandestina, hipótese negada posteriormente pelo ministro. Uma lancha naufragou durante o trajeto entre Manaus e Nova Olinda do Norte, nas proximidades do Encontro das Águas. Informações preliminares indicam que ao menos 70 pessoas foram resgatadas e que a embarcação não possuía coletes salva-vidas. O Corpo de Bombeiros do Amazonas foi acionado e a ocorrência segue em andamento, sem confirmação oficial do número de vítimas e feridos. A deputada federal Adriana Ventura (Novo-SP) reúne assinaturas para protocolar uma proposta de emenda à Constituição que torna obrigatória a adoção de um código de conduta e integridade no Judiciário brasileiro, incluindo ministros do STF e de tribunais superiores. Para começar a tramitar, a PEC precisa de 171 assinaturas, e, segundo a assessoria da parlamentar, 46 apoios já foram obtidos. O ministro do Empreendedorismo, Márcio França, afirmou estar apto a disputar o governo de São Paulo nas eleições de 2026, mas destacou que a decisão final caberá ao presidente Lula. Outros nomes, como Fernando Haddad, Simone Tebet e Geraldo Alckmin, também são cotados para compor uma eventual chapa do PT no estado.O presidente Lula se reuniu com o senador Rodrigo Pacheco e voltou a defender que ele dispute o governo de Minas Gerais para fortalecer o palanque do PT em 2026. Apesar da insistência, o parlamentar manteve a indefinição sobre a candidatura e afirmou que só concorreria se não houvesse alternativa competitiva no estado. A Câmara dos Deputados analisa um projeto de lei que prevê o pagamento de um 13º salário para famílias beneficiárias do Bolsa Família. A proposta busca garantir um fim de ano com maior suporte financeiro aos inscritos no programa social, mas ainda depende de tramitação e aprovação no Congresso Nacional. O Tribunal Superior Eleitoral indicou que o presidente Lula (PT) ainda pode sofrer sanções relacionadas ao desfile da escola Acadêmicos de Niterói, que prestará homenagem ao político. Apesar de não impedir a apresentação, a Corte fez ressalvas e manteve o processo em aberto, permitindo que partidos acionem novamente o TSE caso entendam que houve ato eleitoral antecipado. Você confere essas e outras notícias em Os Pingos nos Is.

O TSE rejeitou, por unanimidade, as ações do Novo e do Partido Missão contra o desfile da escola de samba Acadêmicos de Niterói, que vai homenagear Lula no Carnaval.Ao votar, a presidente do tribunal, Cármen Lúcia, disse que a rejeição não representa um “salvo-conduto” para ilícitos.Duda Teixeira e Madeleine Lacsko comentam:Papo Antagonista é o programa que explica e debate os principais acontecimentos do   dia com análises críticas e aprofundadas sobre a política brasileira e seus bastidores.     Apresentado por Madeleine Lacsko, o programa traz contexto e opinião sobre os temas mais quentes da atualidade.     Com foco em jornalismo, eleições e debate, é um espaço essencial para quem busca informação de qualidade.     Ao vivo de segunda a sexta-feira às 18h.    Apoie o jornalismo independente. Assine O Antagonista e Crusoé com 10% via Pix ou Google Pay   https://assine.oantagonista.com.br/  Siga O Antagonista no X:  https://x.com/o_antagonista   Acompanhe O Antagonista no canal do WhatsApp. Boletins diários, conteúdos exclusivos em vídeo e muito mais.  https://whatsapp.com/channel/0029Va2SurQHLHQbI5yJN344  Leia mais em www.oantagonista.com.br | www.crusoe.com.br 

O TSE rejeitou, por unanimidade, as ações do Novo e do Partido Missão contra o desfile da escola de samba Acadêmicos de Niterói, que vai homenagear Lula no Carnaval.Ao votar, a presidente do tribunal, Cármen Lúcia, disse que a rejeição não representa um “salvo-conduto” para ilícitos.Duda Teixeira e Madeleine Lacsko comentam:Papo Antagonista é o programa que explica e debate os principais acontecimentos do   dia com análises críticas e aprofundadas sobre a política brasileira e seus bastidores.     Apresentado por Madeleine Lacsko, o programa traz contexto e opinião sobre os temas mais quentes da atualidade.     Com foco em jornalismo, eleições e debate, é um espaço essencial para quem busca informação de qualidade.     Ao vivo de segunda a sexta-feira às 18h.    Apoie o jornalismo independente. Assine O Antagonista e Crusoé com 10% via Pix ou Google Pay   https://assine.oantagonista.com.br/  Siga O Antagonista no X:  https://x.com/o_antagonista   Acompanhe O Antagonista no canal do WhatsApp. Boletins diários, conteúdos exclusivos em vídeo e muito mais.  https://whatsapp.com/channel/0029Va2SurQHLHQbI5yJN344  Leia mais em www.oantagonista.com.br | www.crusoe.com.br 

O State of Play de fevereiro de 2026 veio recheado de anúncios. Entre eles, o Kratos do velho testamento está de volta! A trilogia da era grega de God of War vai ganhar remake, mas além disso, ganhamos de surpresa uma aventura na juventude de Kratos com God of War: Sons of Sparta. Além disso, cada vez mais perto do lançamento, Resident Evil Requiem chegou com um quarto trailer trazendo uma localidade icônica para os fãs da série.Bora rever os destaques da semana no Flow Games News de hoje!

O longuíssimo comboio de tempestades está quase a passar. Deixou um rasto de destruição que será difícil de esquecer. Que o diga a ex-ministra da Administração Interna, Maria Lúcia Amaral, que se demitiu literalmente no olho do furacão. Algumas horas depois, um segmento da A1 desaparecia no rio Mondego. O primeiro-ministro assumiu a pasta temporariamente. Em Belém, Luís Montenegro vai passar a encontrar António José Seguro, eleito Presidente da República como o político português mais votado de sempre. A análise de Clara Ferreira Alves, Luís Pedro Nunes, Daniel Oliveira e Pedro Marques Lopes no Eixo do Mal em podcast. Emitido na SIC Notícias a 12 de fevereiro. Para ver a versão vídeo deste episódio clique aquiSee omnystudio.com/listener for privacy information.

Nesta edição, analisamos as novas regras do PAT (Programa de Alimentação do Trabalhador) que já estão valendo: teto de 3,6% para taxas de administração e reembolso em 15 dias, injetando capital de giro vital para o setor. Discutimos também o papel dos apps de supermercado, usados por 75% dos consumidores para planejamento, e como a tecnologia não substitui o "olho no olho".Exploramos a tendência da loja física como palco de experiências, com chefs assinando cardápios e clubes infantis, e o sucesso dos mercados autônomos que crescem garantindo o "básico bem feito".Entre os destaques:

Hoje, ‘No Pé do Ouvido, com Yasmim Restum, você escuta essas e outras notícias: Exposto por um relatório da PF, ministro tentou se manter à frente do inquérito, mas foi convencido a deixar relatoria após reunião longa e tensa com demais integrantes do Supremo. TSE rejeita, por unanimidade, ações que questionavam homenagem de escola de samba do Rio a Lula. Alertas de desmatamento caem na Amazônia e no Cerrado, diz Inpe. MPF dá cinco dias para X bloquear nudez criada com o Grok. E confira as dicas off-Carnaval da agenda cultural para Rio e São Paulo.See omnystudio.com/listener for privacy information.

A Fórmula 1 encerrou nesta sexta-feira (13) a primeira bateria de testes pré-temporada no Bahrein. E o Motorsport.com chega com uma análise completa de tudo que rolou durante os três dias de atividades no Sakhir, projetando ainda a próxima fase da pré-temporada, entre os dias 18 a 20 de fevereiro. Guilherme Longo (@gglongo) comanda a ação ao lado dos comentaristas Erick Gabriel (@erickjornalista) e Isa Fernandes (@isamfer_).

Verden igen og igen er blevet betegnet som usikker, præget af toldkrig og trusler. Men det påvirker åbenbart ikke de største danske aktieselskaber. En foreløbig opgørelse viser nemlig at selskaber som Novo, Mærsk og Ørsted har investeret massivt i 2025 og meget tyder på at investeringerne som minimum skal prioriteres på lige fod med aktieopkøb og -udbetalinger. Hør i denne Finans Lyn-analyse, hvorfor selskaberne vælger at investere, selvom den globale krise kradser og recession måske lurer forude. Gæst: Daniel Skinbjerg, journalist, Finans. Vært: Mads Ring. Foto: Ørsted/PR. See omnystudio.com/listener for privacy information.

Viajamos no tempo como um ninja, e depois um samurai, e depois um ninja em busca de vingança no receptivo Nioh 3. Comentamos também as demissões e futuro de 2XKO, Overwatch perdendo o número 2, o anúncio de Horizon Hunters Gathering, os resultados do PlayStation e da Obsidian e mais! Comece seu dia com a INSIDER #insiderstore Nosso cupom: JOGABILIDADE 00:08:59: Riot demite desenvolvedores de 2XKO 00:19:34: Blizzard remove o 2 de Overwatch 00:32:47: Novo CEO na Remedy Entertainment 00:34:37: Horizon Hunters Gathering foi anunciado 00:51:48: Resultados do trimestre do Playstation 01:06:26: O preço do Switch 2 01:12:26: Valve adia a Steam Machine 01:16:27: Resultados da Obsidian 01:23:08: Devs de Clair Obscur: Expedition 33 são condecorados 01:33:35: Série de Baldur's Gate 3 da HBO 01:40:38: Nioh 3 02:29:06: Perguntas dos ouvintes 02:42:33: Finalmentes Contribua | Twitter | YouTube | Twitch | Contato

Confira nesta edição do JR 24 Horas: A Polícia Civil de São Paulo realizou, nesta quinta-feira (12), uma operação contra um esquema de lavagem de dinheiro da máfia chinesa no Brasil. A Justiça autorizou o cumprimento de 20 mandados de busca e apreensão e três de prisão em São Paulo e Santa Catarina, além do bloqueio de bens e valores que podem chegar a R$ 36 bilhões. Segundo as investigações, mais de R$ 1 bilhão teriam sido movimentados pelos suspeitos, que atuam no mercado de vendas de produtos eletrônicos pela internet. Um dos presos na operação seria um dos chefes de uma facção criminosa. E ainda: Novo ataque da Rússia contra a Ucrânia deixa milhares de pessoas sem água e energia. 

Kønsdiversitetsmål trak overskrifter og blev et vigtigt brand for mange af de største virksomheder herhjemme og globalt. Nu skulle ligestillingen ind - også i de øverste ledelseslag. Men her få år efter har store virksomheder som Mærsk og Novo helt fjernet de specifikke målsætninger. Og selvom Novo f.eks. næsten var nået i mål med deres måltal, så begræder flere eksperter udviklingen. Hør i denne Finans Lyn-analyse, hvorfor virksomhederne er blevet varsomme med kønsdiversitetsmål og om mål i sig selv er så vigtige endda. Gæst: Iben Schmidt, journalist, Finans. Vært: Mads Ring. Foto: Arkiv.See omnystudio.com/listener for privacy information.

Silver, Gold and Crypto (oh my) Hang on – Wild ride here Superbowl, Olympics- Wait until you hear about the CAPex spending! Shakeup in Dietville PLUS we are now on Spotify and Amazon Music/Podcasts! Click HERE for Show Notes and Links DHUnplugged is now streaming live - with listener chat. Click on link on the right sidebar. Love the Show? Then how about a Donation? Follow John C. Dvorak on Twitter Follow Andrew Horowitz on Twitter Interactive Brokers  Warm-Up - Silver, Gold and Crypto (oh my) - Need a stock for CTP - Hang on - Wild ride here - Superbowl, Olympics- Wait until you hear about the CAPex spending! - Shakeup in Dietville Markets - Massive moved during the week - - Bitcoin clipped $60k before rebounding - DJIA tops 50,000 for the first time - Wait until you hear about the CAPex spending! - CAT == 1,100 points on the DJIA in 2026 Superbowl and Superbowl ads - Game review - Any ad stick out? - $10M per ad this year - Half Time with Bad Bunny? - Anthropic busting on OpenAi Last Week! - Massive moved - quick calc showed that about $1T was wiped from market caps in the sell-off, particularly in tech names. - HOWEVER - Friday alone is estimated to have added $1.5T to market cap AI Ripping Through - Plenty of names getting cooked over AI announcements - First it was the software companies - Now there are names in legal and finance that got clocked - Today - Altruist.ai can do tax planning and that hurt companies in financial space Earnings Season Update - Reporting so far: 59% of S&P 500 companies have reported Q4 2025 results. - Beat rate: 76% have topped EPS estimates (vs. 5-yr average: 78% (slightly lower) vs. 10-yr average: 76% (in line) - Magnitude of beats (aggregate): earnings are 7.6% above estimates vs. 5-yr average: 7.7% (about the same) vs. 10-yr average: 7.0% (a bit better) - Nothing great,  like Goldilocks Earnings Highlights - Palantir (PLTR): Reported strong Q4 results early in the week , beating estimates with revenue ~$1.41B (vs. ~$1.33B expected) and EPS $0.25 (vs. $0.23). Guidance for 2026 was upbeat (~61% revenue growth). Shares rallied sharply initially (~7–11% post-earnings), but gave back some gains amid broader tech volatility (e.g., down ~11–22% in parts of the week from peaks). - AMD: Reported mid-week, beating EPS (~$1.53 vs. lower expectations) with solid data center growth (~39%). However, Q1 guidance disappointed relative to high expectations in the AI chip space. Shares sank dramatically — down ~15–17% the next day, with some reports noting up to 20%+ drops at points, contributing to broader chip sector pressure. - Alphabet (GOOGL/GOOG): Reported beating on revenue (~$113.8B) and EPS (~$2.82), with strong core performance. But capex guidance for 2026 ($175–$185B, roughly double prior levels) sparked AI spending worries. Shares dipped post-earnings (down ~0.5–5% initially, flat to lower the next day, with some volatility pulling it below key moving averages). - Amazon (AMZN): Reported after hours on February 5, with mixed results — EPS ~$1.95 (narrow miss vs. ~$1.97 expected), but solid overall. The big negative was a surprise $200B capex forecast for 2026 (well above expectations), tied to AI/cloud buildout. Shares plunged sharply — down ~7–10% in after-hours/extended trading, with Friday moves around -5–8% in some sessions. Recent Tech CAPEX announcements - Amazon (AMZN) — Guided to approximately $200 billion in capex for 2026 (a massive jump from ~$125–131 billion in 2025, with ~80% likely AI-related per analyst commentary). This was the largest single-company figure and a major surprise, contributing heavily to the week's "wild" reactions. - Alphabet (GOOGL/GOOG) — Guided to $175–185 billion in capex for 2026 (roughly double the $91 billion spent in 2025, far above analyst expectations of ~$115–119 billion). Emphasis was on AI compute capacity, servers, data centers, and networking to meet demand for Gemini and cloud services. - Meta Platforms (META) — Guidance from late January (but heavily discussed last week): $115–135 billion for 2026 (up significantly from ~$70–72 billion in 2025, potentially an ~87% increase). - Microsoft (MSFT) — No new full explicit 2026 guidance in early February (fiscal year runs July–June), but recent quarterly run-rate and analyst projections put it around $97–145 billion (with some sources citing ~$105 billion or higher based on Q2 spending trends and signals of continued growth from prior levels of ~$88 billion in FY2025). ------!!!!Combined 2026 capex projected at $635–665 billion (low/high ends) or up to $650–700 billion in some reports — a ~60–74% increase from their collective ~$381 billion in 2025. Market Reaction from all of this.... - Markets were a bit spooked on the Anthropic announcement earlier in the week - software sold off and set a sour mood - Microsoft dumped pretty hard as the amount of spend was higher than anticipated, especially with some slower growth in Azure. - Amazon took a beating on the increased spend they anticipate *(extra by $50B) - BUT: Friday markets rallied as there was realization that the $200B spend by Amazon would seep into the economy and fuel infrastructure spending along with chips, tech etc. Other Earnings of Interest -  Reddit reported fourth-quarter earnings on Thursday in which the social media company beat on the top and bottom lines. - The company said it expects first-quarter sales to come in the range of $595 million to $605 million, which is higher than Wall Street expectations of $577 million. - Reddit also announced a $1 billion share repurchase program. - Reddit gets about $250 million a year from OpenAi and Google to have your data for training their LLMs While we are on the subject - Friday, DJIA hit 50,000 - first time ever! - Up 1,200 point of which approx 350 was from caterpillar and 280 was from Goldman Sachs Hats off to WalMart - Walmart Inc. shares pushed its market capitalization past $1 trillion on Tuesday for the first time ever| - Big transformation over the pst year - Walmart has maintained its appeal to households looking for value, its online offerings are drawing new, wealthier shoppers seeking convenience. Google Bond Offering - Issuing several tranches of bonds, denominated in Stirling - one as long as 100 years - Would you buy that? - The Google parent is set to raise $20 billion from a US dollar bond offering on Monday — more than the $15 billion initially expected — and is also pitching investors on what would be its first ever offerings in Switzerland and the UK. - The latter would include a rare sale of 100-year bonds, the first time a tech company has tried such an offering since the dotcom frenzy of the late 1990s Fat Profits in Dietville - Really interesting sequence of events happening... - Hims launches compounded pill at prices as low as $49 per month - Analysts cite questions on efficacy, legality of pill - Hims' move shifts focus from Novo's strong Wegovy pill launch - Broader obesity market whipsawed as pricing pressure rises THEN.. - Hims and Hers Health shares dive 14% after hours on Friday (Down 25% on Monday) - FDA cites concerns over quality, safety, federal law - The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims & Hers, for its $49 weight-loss pill, including restricting access to the drug's ingredients and referring the company to the Department of Justice for potential violations of federal law. AND.... - Eli Lilly last Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soars. - The pharmaceutical giant anticipates its 2026 revenue will come in between $80 billion and $83 billion. Analysts expected revenue of $77.62 billion, according to LSEG. - Meanwhile, NOVO had a really bad outlook that took the shares down 13% after the report. Japan Markets Soar - Japanese stocks jumped to a record high Monday, leading gains in the region after Prime Minister Sanae Takaichi won a landmark election victory. - The ruling Liberal Democratic Party captured a two-thirds supermajority in the 465-seat lower house, public broadcaster NHK reported. - Japan's Nikkei 225 jumped past 57,000 for the first time before paring gains to close 3.9% higher at 56,363.94, while the Topix also notched a record high, closing at 3,783.94, up 2.3%. Employment Report? - Government shutdown is forcing them to postpone again (Which is dumb) - Number due this Wednesday - Maybe because of this:U.S. employers announced 108,435 layoffs for the month, up 118% from the same period a year ago and 205% from December 2025. The total marked the highest for any January since 2009. - At the same time, companies announced just 5,306 new hires, also the lowest January since 2009, which is when Challenger, Gray & Christmas began tracking such data. - Also, job openings fell sharply in December to 6.54 million, to their lowest since September 2020. - Available jobs are down by more than 900,000 just since October. - NO! Ai and advancements in tech have noting to do with this! NO NO NO M&A - Texas Instruments Inc. has reached an agreement to buy Silicon Laboratories Inc. for about $7.5 billion, deepening its exposure to several markets for chips. - Silicon Labs investors will receive $231 in cash for each share of the company's common stock and the transaction is expected to close in the first half of 2027. - The transaction still needs to win approval by investors in Silicon Labs and shares of Silicon Labs surged by 51% to $206.48 after the announcement. Inflation - This helps - PepsiCo (PEP.O), opens new tab will cut prices on core brands such as Lay's and Doritos by up to 15% following a consumer backlash against several previous price hikes, the snacks and beverage maker said on Tuesday after it topped fourth-quarter results. Miran - Moving - Federal Reserve Governor Stephen Miran is leaving his post as chair of the Council of Economic Advisers, CNBC has confirmed. - He joined the CEA in January 2025, but had been on leave from that post since last September when he filled the unexpired term of former Fed Governor Adriana Kugler.- He reamins on Fed board No Biggie???? - There are some astonishing cased being reported of Bad AI in the operating room - JNJ's TruDi Navigation System - Since AI was added to the device, the FDA has received unconfirmed reports of at least 100 malfunctions and adverse events. - At least 10 people were injured between late 2021 and November 2025, according to the reports. Most allegedly involved errors in which the TruDi Navigation System misinformed surgeons about the location of their instruments while they were using them inside patients' heads during operations. - Cerebrospinal fluid reportedly leaked from one patient's nose. In another reported case, a surgeon mistakenly punctured the base of a patient's skull. In two other cases, patients each allegedly suffered strokes after a major artery was accidentally injured. Cuba - The main airport has putt out a bulletin that they are out of Jet Fuel - Blackouts and lack of other fuels are creating big problems - No airlines have stopped running at this point, but many will as they cannot refuel - This is a bigger problem for cargo planes (supplies) that may not be able to risk flying to Cuba as they will not be able to get out. Love the Show? Then how about a Donation? ANNOUNCING THE WINNER OF THE THE CLOSEST TO THE PIN CUP 2025 Winners will be getting great stuff like the new "OFFICIAL" DHUnplugged Shirt!     FED AND CRYPTO LIMERICKS   See this week's stock picks HERE Follow John C. Dvorak on Twitter Follow Andrew Horowitz on Twitter

Confira os destaques de Os Pingos nos Is desta terça-feira (10):A defesa do ex-presidente Jair Bolsonaro (PL) deve apresentar um novo pedido de prisão domiciliar, segundo anúncio feito por Carlos Bolsonaro nas redes sociais. O argumento é baseado em laudos da Polícia Federal e do médico assistente que apontam comorbidades relevantes e riscos elevados à saúde do ex-presidente. O Brasil manteve em 2025 a segunda pior nota de sua série histórica no Índice de Percepção da Corrupção, divulgado pela Transparência Internacional. O país registrou 35 pontos em uma escala de 0 a 100 e ficou na 107ª posição entre 182 nações avaliadas. Apesar da leve alta em relação a 2024, a variação é considerada estatisticamente insignificante, indicando estagnação na percepção sobre corrupção no setor público. Entidades do setor produtivo demonstraram preocupação com a proposta de acabar com a escala de trabalho 6x1, que pode gerar impactos bilionários nos custos das empresas. Representantes da indústria também criticam a condução do debate em Brasília e afirmam não terem sido chamados para discutir o tema. O presidente da Câmara, Hugo Motta, quer votar a medida até maio. Estudo do Instituto de Pesquisa Econômica Aplicada (Ipea) indica que a redução da jornada semanal para 40 horas elevaria o custo médio do trabalho celetista em 7,84%, impacto semelhante a aumentos recorrentes do salário mínimo. Apesar disso, a pesquisa aponta que a maioria dos setores conseguiria absorver a mudança. Hoje, grande parte dos trabalhadores formais ainda cumpre jornadas de 44 horas semanais. O ministro da Fazenda, Fernando Haddad, afirmou que continua conversando com o presidente Lula sobre uma possível candidatura ao governo de São Paulo em 2026. Apesar das pressões políticas, o ministro disse que seguirá ouvindo o presidente antes de tomar uma decisão definitiva sobre a disputa no maior colégio eleitoral do país. O presidente nacional do MDB, Baleia Rossi, reuniu-se com o governador de São Paulo, Tarcísio de Freitas, e afirmou que a conversa reforçou a parceria entre a sigla e o governo paulista. O encontro ocorre enquanto o presidente Lula (PT) tenta atrair o MDB para sua chapa à reeleição, inclusive com a possibilidade de indicar um vice do partido. Nos bastidores, o movimento é visto como sinal de disputa interna sobre o rumo da legenda em 2026. O ex-governador do Rio de Janeiro, Wilson Witzel, anunciou sua pré-candidatura ao governo do estado. Cassado em 2021 após suspeitas de desvios de recursos na saúde durante a pandemia, o político afirma estar mais experiente e preparado para retornar à vida pública. Para disputar as eleições, Witzel busca uma nova sigla de centro-direita. Você confere essas e outras notícias em Os Pingos nos Is.

O programa Meio-Dia em Brasília desta quarta-feira, 11 de fevereiro, fala sobre a representação apresentada pelo partido Novo questionando o desfile da escola de samba Acadêmicos de Niterói que vai homenagear o presidente Lula.Além disso, o jornal também fala sobre o folgão de Carnaval dos deputados federais e sobre um vídeo envolvendo o líder do governo no Congresso, Randolfe Rodrigues (PT-AP), que tem sido ridicularizado nas redes sociais.Meio-Dia em Brasília traz as principais notícias e análises da política nacional direto   de Brasília.     Com apresentação de José Inácio Pilar e Wilson Lima, o programa aborda os temas mais quentes do cenário político e econômico do Brasil.     Com um olhar atento sobre política, notícias e economia, mantém o público bem informado.   Transmissão ao vivo de segunda a sexta-feira às 12h.   Apoie o jornalismo independente. Assine O Antagonista e Crusoé com 10% via Pix ou Google Pay   https://assine.oantagonista.com.br/   Siga O Antagonista no X:  https://x.com/o_antagonista   Acompanhe O Antagonista no canal do WhatsApp. Boletins diários, conteúdos exclusivos em vídeo e muito mais.  https://whatsapp.com/channel/0029Va2SurQHLHQbI5yJN344  Leia mais em www.oantagonista.com.br | www.crusoe.com.br 

O Partido Novo protocolou nesta terça-feira (10) uma representação no Tribunal Superior Eleitoral (TSE) por propaganda eleitoral antecipada contra o presidente Luiz Inácio Lula da Silva, o PT e a escola de samba Acadêmicos de Niterói.A ação questiona o enredo "Do alto do mulungu surge a esperança: Lula, o operário do Brasil", que homenageará o mandatário na Sapucaí. A oposição argumenta que o desfile utiliza elementos típicos de campanha, como o número 13 e jingles históricos, o que comprometeria a isonomia do processo eleitoral de 2026.Meio-Dia em Brasília traz as principais notícias e análises da política nacional direto   de Brasília.     Com apresentação de José Inácio Pilar e Wilson Lima, o programa aborda os temas mais quentes do cenário político e econômico do Brasil.     Com um olhar atento sobre política, notícias e economia, mantém o público bem informado.   Transmissão ao vivo de segunda a sexta-feira às 12h.   Apoie o jornalismo independente. Assine O Antagonista e Crusoé com 10% via Pix ou Google Pay   https://assine.oantagonista.com.br/   Siga O Antagonista no X:  https://x.com/o_antagonista   Acompanhe O Antagonista no canal do WhatsApp. Boletins diários, conteúdos exclusivos em vídeo e muito mais.  https://whatsapp.com/channel/0029Va2SurQHLHQbI5yJN344  Leia mais em www.oantagonista.com.br | www.crusoe.com.br 

O recé-eleito Presidente Seguro (antes, António Jé) vai iniciar uma nova etapa da sua vida. Que desafios o esperam a nível internacional? Quem serão os seus amigos? E os seus inimigos?

This Day in Legal History: Nelson Mandela ReleasedOn February 11, 1990, Nelson Mandela was released from Victor Verster Prison in South Africa after 27 years of incarceration, marking a seismic shift in the country's legal and political landscape. Mandela's release followed a period of secret negotiations between the apartheid government and the African National Congress (ANC), and it signaled the beginning of the end of apartheid—a system of institutionalized racial segregation and oppression upheld by law. His imprisonment had become a global symbol of the fight against racial injustice and was frequently challenged by international human rights organizations and legal scholars as a violation of fundamental human rights.Mandela had been convicted in 1964 of sabotage and other charges under South Africa's Suppression of Communism Act, following the infamous Rivonia Trial. He was sentenced to life imprisonment, spending much of his sentence on Robben Island under harsh conditions. Over the decades, growing international sanctions and internal unrest made apartheid increasingly untenable.Then-President F.W. de Klerk's government began rolling back apartheid legislation in the late 1980s, and on February 2, 1990, de Klerk announced the unbanning of the ANC and his intention to release Mandela. Just nine days later, Mandela walked free, delivering a speech in Cape Town that emphasized reconciliation, peace, and the continuation of the struggle for full democratic rights.Mandela's release was not just a political milestone—it was a legal one, too. It reflected a move away from laws based on racial supremacy and toward a constitutional order grounded in human rights. This transformation would culminate in South Africa's 1996 Constitution, often lauded for its rights-based framework and independent judiciary.The Trump administration's plan to repeal the EPA's 2009 endangerment finding—the scientific basis for regulating greenhouse gases under the Clean Air Act—could reignite legal efforts to hold polluters accountable through public nuisance lawsuits. That finding enabled the EPA to regulate emissions from vehicles and power plants, but its reversal removes the legal framework that had previously shielded companies from such claims under a 2011 Supreme Court ruling. In that decision, the Court held that the EPA's authority under the Clean Air Act displaced common-law nuisance suits against emitters. Without that EPA oversight, legal scholars believe plaintiffs may now argue that the courts are once again an appropriate venue for these claims.Public nuisance lawsuits, typically filed by states or municipalities, seek to hold companies accountable for harms caused to community health and safety. These cases have been historically difficult to win due to challenges in proving direct causation, but experts say the new regulatory gap could encourage a wave of litigation. Industry groups like the Edison Electric Institute have warned that repealing the endangerment finding could expose utilities to costly legal battles. While federal courts had largely blocked such claims, state courts have shown more openness, and the shift in federal policy may strengthen these legal efforts. Environmental advocates may now have renewed leverage to push power companies and other emitters into court.Trump's repeal of climate rule opens a ‘new front' for litigation | ReutersAttorney General Pam Bondi is scheduled to testify before the House Judiciary Committee this week amid intensifying legal scrutiny over the Justice Department's management of the Jeffrey Epstein files. Lawmakers are expected to question Bondi about what they view as excessive redactions and the DOJ's withholding of key documents, actions that may conflict with a bipartisan federal law passed in 2025 mandating the broad release of Epstein-related materials. Legal analysts suggest the DOJ's reliance on legal privileges—such as investigatory and deliberative process exemptions—to justify redactions could face stiff challenges in court or through congressional oversight powers.The situation raises constitutional tensions between legislative oversight and executive privilege, particularly as the House panel, now under Republican control, examines whether the DOJ is shielding politically sensitive information. Some members of Congress have accused the Department of undermining transparency and potentially violating the statutory intent of the Epstein Disclosure Act, which narrowed the DOJ's discretion in withholding records tied to convicted sex offenders or deceased suspects like Epstein.Bondi's DOJ has been accused of prioritizing partisan enforcement over institutional neutrality, illustrated by failed prosecutions of Trump critics and an aggressive posture on immigration and protest-related cases. The sidelining of the DOJ's civil rights division and the refusal to investigate federal shootings has further fueled concerns over selective enforcement and erosion of prosecutorial independence. Bondi's testimony will serve as a key moment to defend the Department's use of legal redactions and its broader approach to politically charged prosecutions.Bondi to face questions on Epstein files in House testimony | ReutersInstagram chief Adam Mosseri is set to testify in a Los Angeles courtroom this week in a groundbreaking lawsuit that could reshape how U.S. law approaches the intersection of product design and youth mental health. The case centers on a 20-year-old plaintiff who alleges she became addicted to Instagram as a child due to its deliberately addictive interface—particularly the “endless scroll” feature that loads content continuously to hold user attention. Her lawyers argue that Instagram's design choices amount to a form of negligent product engineering that failed to account for known risks to children.This case raises novel legal questions: Can user interface (UI) design be treated as a defective product under tort law? Can tech companies be held liable not just for content but for the architecture of the platforms themselves? If the court accepts these arguments, it could establish precedent for treating addictive design as a public health harm similar to tobacco or opioid marketing practices.Mosseri is expected to face questioning over internal documents that, according to the plaintiff, show Meta was aware of the app's mental health impact on vulnerable teens. Meta counters that these documents reflect efforts to mitigate harm, not evidence of negligence. Still, the case may test the limits of Section 230 immunity, as it focuses not on third-party content, but the platform's own design—potentially sidestepping the traditional legal shield for tech companies.Hundreds of similar cases are pending, and this trial may serve as a bellwether for litigation nationwide. International developments, including Australia's ban on social media for children under 16, suggest this is a growing legal frontier.Instagram's leader to testify in court on app design, youth mental health | ReutersNovo Nordisk's recent patent infringement lawsuit against Hims & Hers marks a pivotal legal development in the pharmaceutical industry's battle with telehealth providers distributing compounded drugs. The suit, filed in Delaware federal court, targets Hims' sales of compounded semaglutide—the active ingredient in Wegovy and Ozempic—claiming these formulations infringe Novo's patents. While compounding is allowed under certain FDA exemptions, those exemptions do not shield pharmacies or telehealth platforms from patent liability. This case challenges the assumption that FDA compliance protects against infringement claims, exposing a gray area where regulatory and intellectual property regimes collide.Historically, brand-name drugmakers focused on trademark challenges over how compounded drugs were marketed. Novo's move into patent litigation signals a strategic escalation: it's not about branding anymore—it's about the act of making and selling the compound itself. Experts highlight that this is likely the first time a brand drug company has pursued patent claims directly against a compounding pharmacy or telehealth distributor, suggesting the industry now sees these entities as substantial commercial threats.The case also underscores a novel enforcement strategy: suing the telehealth platform facilitating sales rather than the dispersed network of compounding pharmacies, streamlining legal action and potentially setting precedent for centralized liability. Hims, already under regulatory scrutiny, had just halted plans to sell compounded semaglutide pills but remains a target due to its involvement in injectable forms.The outcome of this case may clarify how FDA-sanctioned compounding intersects with patent protections and could define the boundaries for how far telehealth companies can go in offering customized versions of patented drugs.Novo's GLP-1 Patent Suit Against Hims Takes Aim at Compounding This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

No Desculpa Alguma Coisa desta semana, Tati Bernardi recebe a chef Bel Coelho.

No Falando de Nada desta semana, comentamos o show do My Chemical Romance que a Aline foi conferir e o Press Day da Apple em Los Angeles, com detalhes sobre como funciona o evento e os principais filmes e séries apresentados por lá.Também tem entrevista com o diretor Pedro Morelli, em um papo focado no o filme Salve Geral - Irmandade; da Netflix, falando sobre o processo de produção e os impressionantes planos-sequência.Seja um membro da Guilda dos Tagarelers e participe das pautas semanais:https://www.youtube.com/channel/UCa8ekYf6l76ikQszoMYuHkw/join00:00 - Começou o Falando de Nada!01:20 - Aline foi no show do My Chemical Romance07:49 - Michel conta como foi o Press Day da AppleTV em L.A17:32 - Séries e Filmes da Apple em 202633:51 - Entrevista com o diretor Pedro MorelliQuer enviar um Pix da Alegria? Entre em contato com nosso produtor @bclemente22 no Instagram!✉ Quer mandar sua sugestão de pauta ou dúvida? Envie um e-mail para

Last Thursday, Hims & Hers launched a compounded versionof Novo's oral Wegovy, approved just before Christmas and launched in early January. Novo was, not surprisingly, none too pleased. FDA Commissioner Marty Makary denounced“illegal copycat drugs” in an X post the same day without naming Hims, which then said it would notsell the oral weight loss drug. Novo sued the consumer healthcare company for patent infringement, seeking potentially hundreds of millions in damages. Thenit emerged that FDA hit Hims with a warning letter last year about infestations of vermin at a facility it owns, including rodents, birds and insects, as well as a live spider in a production area.The timing of all the Hims drama is interesting, because BioSpace was already covering Novo, Lilly and their blockbuster GLP weight loss drugs as both companies—and others—reported 2025 fourth quarter and full year earnings. EliLilly and Novo both reported last Wednesday, and both spoke of Novo's oral Wegovy launch positively. But the calls had two very different tones, as Lilly beat Q4 2025 analyst consensus by more than a billion dollars while Novo projected sales to decline by 5% in 2026.In other recent earnings calls, AbbVie touted strong Skyriziand Rinvoq sales, and the company continues to follow Johnson & Johnson's lead into the psychedelics space. And Biogen discussed the highly anticipated readout of its tau-targetingtherapy for Alzheimer's.Finally, in gene therapy, Sarepta struggles to recover from last year's patient deaths as other DMD contenders near the market; uniQure pauses two arms of a clinical trial for Fabry disease; and Ultragenyx resubmits its in vivo gene therapy UX111 for the treatment of Sanfilippo syndrome type A.

Hoje, ‘No Pé do Ouvido, com Yasmim Restum, você escuta essas e outras notícias: Após segunda denúncia de assédio sexual, STF afasta ministro Marco Buzzi. Novo documento sugere que Trump sabia dos crimes de Epstein antes do início de investigações. Ataque a tiros no Canadá deixa dez mortos. Governo paga R$ 1,69 bilhão em emendas parlamentares neste início de ano. Governo de SP sanciona lei que autoriza sepultamento de animais em jazigos de tutores. E branqueamento de corais atingiu cerca de 80% dos recifes do planeta.See omnystudio.com/listener for privacy information.

Galaxy S26: site vaza ficha técnica completa e preços de todos os celulares e Samsung confirma data do Unpacked 2026; saiba o que esperar! Motorola Signature: novo celular de ponta ganha data de lançamento no Brasil. Pegadinha do Silvio Santos está nos arquivos Epstein. Taiwan diz ser "impossível" migrar 40% da produção de chips para os EUA e quais os direitos de quem é filmado sem autorização por óculos inteligentes?

Alta do bezerro e retenção de fêmeas sinalizam início do ciclo de alta da pecuária brasileira

No quadro FALA PECUARISTA o movimento de alta dos bezerros no Pará, celeiro de reposição no Brasil ; No quadro MANEJO EFICIENTE , Milho ou Polpa Cítrica , quando, como e porque usar essas fontes energéticas para o gado

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: T1D in the Olympics & Superbowl, Trump RX goes live, Ozempic pill available soon, tech updates from Medtronic, Beta Bionics, Eversense 365 and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Quick reminder: We are just over one week from our first Moms' Night Out event of the year. While the plans are all set – the speakers, the vendors, the raffles and the fun is ready to go, it's always amazing how many people hear of these event last minute. That's fine, they're welcome! But if you're thinking of attending a future event – registration is open for We're going to Nashville next March 6-7 and Detroit in September – no need to wait. And we've got Club 1921 events for health care professionals and patient leaders in 6 cities this year! All the info is over at diabetes-connetionss.com events/   Okay.. our top story this week: XX Gotta be a quick shout out to some incredible T1D athletes – we had TWO in the super bowl this past weekend – Chad Muma of the New England Patriots and Logan Brown of the Seattle Seahawks AND there are at least two athletes with type 1 competing at the Winter Olympics. Hannah Schmidt competes in ski cross for Canada – she was diagnosed with Type 1 diabetes at age 12 years old.  Anna FarnSchadt Fernstäd a Czech skeleton racer diagnosed in 2022 after she'd already been to several Olympics. We wish them all the best!   https://english.radio.cz/skeleton-racer-anna-fernstadtova-overcoming-adversity-headfirst-down-ice-8876699 XX The government website TrumpRx.gov is live..  the website does not sell prescription drugs. Instead, it allows people to look up their drugs and then navigate to buy them elsewhere, either from a major drug company or a pharmacy. The 43 drugs listed on the site have prices ranging from $3 to over $5,500. TrumpRx does include warnings that the site may not be the best option to save money on prescriptions. Each product page advises: "If you have insurance, check your co-pay first — it may be even lower." For now, the website says its prices are for people paying with their own money, rather than going through insurance. The only insulin listed right now is Lilly's insulin lispro – and it's the same price as you'd find through Illy's insulin value program. I looked up diabetes meds.. For example, if you have an insurance co-pay of $25 a month for Farxiga, a drug often used for diabetes, you would be paying $182 on TrumpRx. As you can imagine, though ,this is complicated and as with most of our healthcare system, it may be good in some cases and not much help in other.  I'd suggest calling your local pharmacist or checking with your human resource dept. https://www.nytimes.com/2026/02/06/health/trumprx-prescription-drug-prices-consumers.html XX Novo Nordisk will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of this year. The company said the U.S. Food and Drug Administration has approved Ozempic tablets in three different doses. Novo says The new Ozempic name is intended to help patients and health care professionals more easily recognize the available treatment options for type 2 diabetes Semaglutide tablets have been available under the brand name Rybelsus Ruh BELL sis for diabetes since 2019 but with different dosing. The pill is also approved to reduce the risk of certain cardiovascular conditions in adults with type 2 diabetes who are at high risk for these events. The FDA had approved the new doses based on a bioequivalence study and the clinical trial data for Rybelsus, Novo said. https://www.reuters.com/business/healthcare-pharmaceuticals/novo-launch-ozempic-pill-diabetes-second-quarter-this-year-2026-02-04/ XX https://www.contemporarypediatrics.com/view/early-screening-for-type-1-diabetes-found-effective-in-children XX Possible new way to identify and track the progress of type 1 diabetes before clinical onset. A recent study published in Science Advances described the application of subcutaneous microporous scaffolds. These are inserted and have been shown to  identify changes in cancer, multiple sclerosis, and T1D by capturing changes of immune cells over the course of a disease. This is a proof of concept study in mice.. so very early days. https://www.news-medical.net/news/20260204/Implantable-immune-scaffold-predicts-type-1-diabetes-weeks-before-symptoms.aspx XX A large global genetics study shows that many key drivers of Type 2 diabetes operate outside the bloodstream. In a major international project led in part by the University of Massachusetts Amherst and Helmholtz Munich in Germany, researchers linked hundreds of genes and proteins to the disease. The work, published in Nature Metabolism, points to a key challenge in diabetes research: the biology behind rising blood sugar does not play out the same way in every part of the body. It also shows why including people from many backgrounds matters, since genetic clues that stand out in one population may be faint or invisible in another. Huge study, 2.5 million people worldwide comparing patterns across seven tissues tied to diabetes and four global ancestry groups, then asked a simple question: what do you miss if you only measure blood? Across the seven tissues, the researchers found causal evidence pointing to 676 genes. Yet overlap with blood was limited: only 18% of genes with a causal effect in a primary diabetes tissue, such as the pancreas, showed a matching signal in blood. At the same time, 85% of genetic effects observed in diabetes-relevant tissues were completely absent from blood-based analyses. The findings lay out a roadmap for future research aimed at understanding the biological pathways underlying Type 2 diabetes and developing more effective treatments. https://scitechdaily.com/massive-global-study-rewrites-the-biology-of-type-2-diabetes/ XX Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at lowering costs for patients, insurers and small pharmacies The settlement, first reported by Reuters, fits with that goal, and allows the FTC to pare down a case brought by the former Biden administration against Cigna's Express Scripts, UnitedHealth Group Inc's (UNH.N), Optum unit and CVS Health Corp's (CVS.N), CVS Caremark. The case against Optum and Caremark is ongoing. Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing practices. While the industry has already made reforms, the settlement gives the FTC power to enforce broader changes at Express Scripts. The 10-year agreement restricts Express Scripts' ability to engage in practices critics say contribute to high costs, like pocketing rebate payments from drugmakers based on the list price of drugs. The FTC estimates the agreement could save patients as much as $7 billion over a decade. https://www.reuters.com/world/cigna-settles-ftc-insulin-case-commits-overhauling-drug-pricing-2026-02-04/ XX Audio? Congress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone of Federal investment in type 1 diabetes (T1D) research. The President signed the legislation and it is now law. Extends the SDP through December 31, 2026, and increases funding from $160 million to $200 million annually. Strengthens overall funding for the National Institutes of Health (NIH) by $415 million. Increases diabetes research funding at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) by $10 million. Created by Congress and administered by the NIH, the SDP has contributed nearly $3.6 billion to T1D research and has played a role in nearly every major breakthrough in the field. A recent study conducted by Avalere Health shows that of the nearly 3.6 billion invested into the SDP by Congress since the establishment of the program, the Federal Government has realized $50 billion in healthcare savings through improved health outcomes from the use of SDP driven therapies and devices https://www.breakthrought1d.org/news-and-updates/congress-passes-bipartisan-extension-of-the-special-diabetes-program-securing-critical-t1d-research-funding/ XX Dexcom is rolling out what they're calling AI-enabled enhancements to Stelo, further transforming how users track and understand their glucose health. Expanded Smart Food Logging including a comprehensive nutrition database of more than 1M meals that provides a breakdown of calories, carbohydrates, protein, fat, dietary fibers, and more. More ways to meal track including text search, barcode scanning or taking a photo of the meal, creating a seamless and intuitive meal tracking solution. A redesigned Daily Insights feature which will introduce a new interface with more personalized recommendations. The newest features will launch nationwide in the coming weeks.  XX Beta Bionics has received a warning letter from the Food and Drug Administration following an inspection last year, the company disclosed on Friday. The diabetes technology company said in a securities filing that the warning letter concerns non-conformities with the company's quality management system, medical device reporting, and correction and removals. The warning letter has not yet been posted by the FDA.   The company said in the filing that it has already taken actions to improve the processes described in the warning letter, and it is working on a written response to the FDA.   The firm does not expect the warning letter to affect the planned launch of a new insulin patch pump by the end of 2027. Beta Bionics unveiled a prototype of the device, called Mint, last year at the American Diabetes Association's Scientific Sessions. The company also does not expect the warning letter to affect its financial results. https://www.medtechdive.com/news/beta-bionics-receives-fda-warning-letter/811140/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3A+2026-02-04+MedTech+Dive+%5Bissue%3A81423%5D&utm_term=MedTech+Dive&fbclid=IwY2xjawPwhDZleHRuA2FlbQIxMABicmlkETFaUUcyYmNQWldjZ2xudElic3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHouF8M3IstTyslPRgeHWUWVVdOAGOtzPWt_yNFcj9eYruqSPz3e86Iwcbpt8_aem_7q4D97vJVjHKfEwvoyUpgw XX Sequel Med Tech is reviewing co-founder Dean Kamen's ties to Jeffrey Epstein after recently released documents revealed new details about the longstanding relationship between the two men. The documents show that Kamen visited Epstein's island, and remained in contact with him for years after Epstein was convicted of sex crimes involving minors. Kamen has not been accused of any wrongdoing. In a statement, Sequel Med Tech said the Manchester-based company is aware of the documents pertaining to Kamen and – quote - "Sequel's Board of Directors has unanimously decided to engage an external law firm to review these disclosures and provide recommendations aligned with our mission to serve people living with diabetes," Kamen has not issued a statement regarding his reported connection to Epstein.   https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.nbcboston.com/news/local/nh-inventor-placed-on-leave-after-epstein-messages-surface-report-says/3888569/ XX Abbot reports 860 serious injuries linked to the recall of some of its glucose monitoring sensors. We told you about this recall late last year, these numbers are an FDA update.     Abbott said the sensors can provide incorrect glucose readings over extended periods, which could lead to users making dangerous treatment decisions, including eating excessive carbohydrates along with skipping or delaying insulin doses, potentially leading to serious health risks. The company said it has identified and resolved the cause of the issue, which relates to one production line among several that make Libre 3 and Libre 3 Plus sensors.   https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-recalls-glucose-sensors-after-seven-deaths-linked-faulty-readings-2026-02-04/ XX Updates from Medtronic & Senseonics – and a first from Nick Jonas.. right after this..   I'm excited to share that the FDA has cleared the MiniMed 780G system with the Instinct sensor, made by Abbott, for people with type 2 diabetes.  Medicare has also now approved coverage for the Instinct sensor for use with the MiniMed 780G system. This clearance and expanded coverage mean more people will have access to pairing our most advanced automated insulin delivery technology with the Instinct sensor, that offers a smaller, 15-day sensor experience.  They're also launching the MiniMed 780G system Pump Evaluation Program.  This program gives individuals living with diabetes the ability to try the full MiniMed 780G system at no cost for 30 days.† This includes the pump, the sensor of their choice, one month of infusion sets and reservoirs, everything but the insulin. They'll contact your doctor for you to get a prescription and get the process rolling. https://www.medtronicdiabetes.com/pump-evaluation-program XX Senseonics announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark approval – that's European clearance.  This comes on the heels of the launch of Eversense 365 with Sequel Med Tech's twiist pump, marking the first pump integration for the CGM. Senseonics plans to launch Eversense 365 in Germany, Italy, Spain and Sweden in the coming months. Meanwhile, Senseonics continues to work toward an FDA investigational device exemption (IDE) submission for its next-generation Gemini transmitter-less CGM by the end of this year. https://www.drugdeliverybusiness.com/senseonics-ce-mark-eversense-365-cgm/ XX A huge shout out to Dr. Emily Blum, who just accomplished riding 100 miles in Antarctica for Breakthrough T1D! Despite having no direct connection to Type 1 Diabetes, Emily has been riding and fundraising for BreakthroughT1D for 10 years now. She is an integral part of the Georgia Ride team, training and riding many miles, and most importantly has raised tens of thousands of dollars to support the cause of ridding the world of T1D. She is surgeon and deeply involved with medical innovation, with an incredibly busy schedule, but jumped at the chance to take on the challenge of riding a century on every continent. Having already completed North America, Europe, Australia, Asia, and now Antarctica, only Africa and South America remain. Emily rides on and continues to be an inspiration to everyone who meets her. XX   https://diabetes-connections.com/t1d-connection-and-people-magazine-elise-zach-share-their-story/ XX Nick Jonas's becomes the first artist ever to wear a CGM on an album cover - new upcoming solo album Sunday Best, releasing Feb. 6.  The release says: This marks a powerful step forward in normalizing diabetes and raising awareness for the condition on a global scale. This moment adds to the growing visibility of diabetes in pop culture, alongside milestones like a Type 1 diabetes Barbie and Pixar characters wearing diabetes technology.

Gotovo 99 posto Australaca kojima je dijagnosticiran rak imaju troškove koje moraju sami platiti, čak i kada koriste javni zdravstveni sistem. To je šokantan nalaz najnovije nacionalne ankete organizacije Cancer Council Australia, koja sugeriše da finansijsko opterećenje proizlazi i iz direktnih medicinskih troškova i iz indirektnih troškova u svakoj fazi borbe s rakom. Naročito su pogođeni pacijenti iz regionalnih i ruralnih područja.

As ondas de calor estão cada vez mais frequentes no Brasil e isso já mudou a forma como a gente vive, trabalha e consome energia. No novo episódio do Podcast Canaltech, a repórter Elisa Fontes conversa com João Aureliano, conselheiro da ABRAVA e especialista em engenharia de climatização, para entender como a tecnologia dos aparelhos evoluiu, por que o mercado está crescendo tanto e o que realmente faz diferença na hora de economizar na conta de luz. Falamos sobre ar-condicionado inverter, sensores inteligentes, automação, erros comuns no uso, impactos no consumo de energia e o que esperar da próxima geração de eletrodomésticos. Você também vai conferir: WhatsApp prepara algo que muita gente estava esperando, aposta ousada da Xiaomi está chamando atenção no mercado e mudança no YouTube Music pode pegar muita gente de surpresa. Este podcast foi roteirizado e apresentado por Fernada Santos e contou com reportagens de João Melo, Danielle Cassita e Bruno de Blasi, sob coordenação de Anaísa Catucci. A trilha sonora é de Guilherme Zomer, a edição de Natália Improta e a arte da capa é de Erick Teixeira.See omnystudio.com/listener for privacy information.

Regras a serem adotadas pela Comissão da ONU para a Europa cobrem Sistemas de Direção Automatizada, ADS; medidas permitem movimento de veículos sem motorista em vias públicas com disposições uniformes de segurança.

O boletim de hoje destaca o debate global sobre a segurança e privacidade de dados no novo serviço ChatGPT Health. O episódio apresenta também a recomendação europeia para o estetrol (Fylrevy) como nova opção de terapia hormonal na pós-menopausa e os avanços promissores da terapia celular encapsulada para o tratamento do diabetes tipo 1. Acompanhe as notícias que influenciam a segurança digital e a inovação terapêutica no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Acesso o link das fontes aqui:https://portal.afya.com.br/podcasts/carreira/10-02-2026

Dagens ämnen: 0:00 Intro 3:57 Rapporter - Nelly, Lyko m. fl 15:02 EQT och SaaS 24:26 Spotify 26:17 Mag 7 32:32 Hims och Novo 34:36 Index och olja 36:38 Evo och dataspelsbranschen 40:53 Uran 42:46 Veckans Fill or Kill   www.instagram.com/fillorkillpodden   Tack RoboMarkets! http://gorobo.pro/2aue   @RoboMarketsSE Tack @avanzabank! www.avanza.se 

In this company update, we sit down with Mike Spreadborough, Executive Co-Chairman, and Kas De Luca, General Manager of Exploration at Novo Resources (TSX: NVO | ASX: NVO | OTCQX: NSRPF). We dive into the latest project update from the Wyloo Project, situated in the Southern Pilbara region of Western Australia, where the company has identified significant new high-grade targets. The discussion focuses on the emergence of the Wyloo SE and Wyloo SW targets, a 5-kilometer trend that has shifted Wyloo to a high-priority status within Novo's portfolio.  Key Discussion Points: The Evolution of Wyloo: Mike Spreadborough explains how the Wyloo Project moved up the priority list following successful land access and the rising global demand for critical metals like antimony. Discovery of High-Grade Trends: Kas De Luca details the results from systematic sampling, highlighting a 5-kilometer trend with rock chip samples peaking at 482 g/t silver and significant gold-antimony mineralization. Maiden Drill Program: The team outlines plans for a 1,500-meter maiden drill program set for April 2026, designed to test the depth, width, and metal zonation of the vein system. Strategic 2026 Outlook: A look at the broader exploration strategy across the company's portfolio of projects in Australia.    Please email me with any follow up questions for Mike and the team at Novo Resources. My email address is Fleck@kereport.com.     Click here to visit the Novo Resources website to learn more about all the projects and exploration programs.    ---------------------- For more market commentary & interview summaries, subscribe to our Substacks:  The KE Report: https://kereport.substack.com/  Shad's resource market commentary: https://excelsiorprosperity.substack.com/ Investment disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any security or investment product. Investing in equities, commodities, really everything involves risk, including the possible loss of principal. Do your own research and consult a licensed financial advisor before making any investment decisions. Guests and hosts may own shares in companies mentioned.

São quatro da manhã e meu corpo obedece à chamada da minha mente como um médico atende uma chamada de emergência. Levanto para ir ao banheiro, me enganando a ponto de acreditar que estou desperta apenas por necessidades fisiológicas. Evito acender a luz para que o corpo não ache que é dia, esquecendo que é minha mente que está no comando e, para ela, está na hora de despertar e ruminar.Deito a cabeça, tento encontrar algum conforto e tudo que encontro são pensamentos repetitivos: Por que eu aceitei? Por que eu não disse como aquilo me fazia sentir? Como essa pessoa teve coragem de me perguntar isso? Como vou lidar com a culpa das consequências de ter dito sim enquanto eu queria dizer não? A culpa é um estado feito para oprimir, pra nos manter sob controle. E eu me sinto totalmente controlada. Eu sou a Marcela Ceribelli. Esse é o primeiro episódio de Fissuras, um novo quadro do Bom Dia, Obvious em que eu pego aquilo que me persegue — um livro, uma música, uma cena — e tento transformar em linguagem antes que vire sintoma. A fissura de hoje é: seria a ruminação o custo corporal dos nossos consentimentos vazios?Espero que as minhas fissuras se deem bem com as suas.⁠⁠Para conteúdos exclusivos do Bom dia, Obvious, assine a newsletter da Obvious⁠⁠⁠⁠⁠⁠⁠⁠⁠Nos acompanhe também: Marcela Ceribelli no Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@marcelaceribelli⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram da Obvious: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@obvious.cc⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok da Obvious: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@obvious.cc⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Chapadinhas de Endorfina: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@chapadinhasdeendorfina⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Ouça também, outros podcasts da Obvious:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Podcast Chapadinhas de Endorfina.doc⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Podcast Academia do Prazer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Livros da Marcela Ceribelli:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sintomas — e o que mais aprendi quando o amor me decepcionou⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Aurora: O despertar da mulher exausta⁠⁠⁠⁠⁠⁠⁠Livros da Valeska Zanello: clique aquiOuça também:Novo álbum da Lily Alen: West End Girl

Audio roundup of selected biopharma industry content from Scrip over the business week ended February 60, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time – Merck looks to fill Keytruda's shoes; Novartis aims to push through largest expiry period; Novo warns of steep sales decline; Pfizer bullish on obesity; and Lilly expects orforglipron success. Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-JES32O67YRBSLC6UV2JFY5KPBQ/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Confira os destaques de Os Pingos nos Is desta sexta-feira (06):Um laudo médico elaborado por peritos da Polícia Federal aponta que Jair Bolsonaro (PL) possui doenças crônicas, mas tem condições de permanecer preso na Papuda. O relatório deve embasar a decisão do ministro Alexandre de Moraes sobre o pedido de prisão domiciliar apresentado pela defesa do ex-presidente. A Polícia Federal deflagrou a Operação Zona Cinzenta para investigar investimentos da Previdência do Amapá no Banco Master. A ação mira dirigentes do órgão e apura a aplicação de mais de R$ 400 milhões em recursos públicos. O ministro Dias Toffoli determinou o envio de processos relacionados ao Banco Master para a primeira instância da Justiça Federal, ao entender que parte das investigações não envolve autoridades com foro privilegiado. A decisão já impacta casos no Rio de Janeiro e em São Paulo.O presidente do PP, Ciro Nogueira, se reuniu com Lula na Granja do Torto em busca de um acordo político para as eleições no Piauí. A articulação envolve a renovação do mandato de senador e pode redefinir alianças no estado. O ex-deputado federal Eduardo Bolsonaro (PL-SP) cobrou publicamente maior engajamento da direita na pré-candidatura de Flávio Bolsonaro (PL-RJ) à Presidência em 2026. A manifestação reforça a tentativa do grupo de unificar aliados e acelerar articulações políticas para a disputa eleitoral. O ministro Aroldo Cedraz, do Tribunal de Contas da União, decidiu manter o repasse de R$ 1 milhão à escola de samba Acadêmicos de Niterói, mesmo após recomendação contrária da área técnica do tribunal. A controvérsia envolve o samba-enredo em homenagem ao presidente Lula e um pedido do partido Novo que apontava possível desvio de finalidade. O vice-presidente Geraldo Alckmin respondeu às declarações de José Dirceu, que classificou a aliança com Lula como um acordo político. Alckmin agradeceu a confiança do ex-ministro e afirmou que a decisão sobre a próxima chapa presidencial será tomada no momento oportuno. Você confere essas e outras notícias em Os Pingos nos Is.

Seja apoiador do X do ControleCompre seus jogos na Nuuvem! MARCAÇÕES DE TEMPO00:00 - Introdução05:13 - Nintendo revela novos jogos third-party em Direct26:03 - Guerrilla Games revela Horizon: Hunters Gathering34:09 - Overwatch abandona o “2” e revela reformulação em aniversário de 10 anos44:46 - Rapidinhas50:15 - EncerramentoCRÉDITOSApresentação: Claudio Prandoni e Guilherme DiasRoteiro: Guilherme Dias e PH Lutti LippeEdição: Lucas FunchalThumbnail: Lucas G. FerreiraSiga o XdC: YouTube⁠⁠⁠| Instagram | Bluesky | Threads | ⁠⁠⁠Tik Tok⁠⁠⁠⁠⁠⁠Nossas plataformas e redes⁠⁠⁠Contato: contato@xdocontrole.comContato para anunciantes e parcerias: comercialxdc@gmail.com

Market update for Friday February 6, 2026Check out the Public app for incredible investing tools and to support the show (LINK)Follow us on Instagram (@TheRundownDaily) for bonus content and instant reactions.In today's episode:Bitcoin suffers its worst selloff since the FTX collapse as crypto markets melt downAmazon shares slide after the company unveils a massive $200B AI capex planNvidia delays new gaming chips because of memory shortageRoblox pops after blowout bookings growth and strong user momentumHims slides after warning from FDA and Novo about copycat pill A look at the business behind the 2026 Winter Olympics kicking off in Italy

Link promocional para audiência do Narrativas. Beway Idiomas:   https://mkt.bewayidiomas.com.br/?a=16517723  Narrativas analisa os acontecimentos do Brasil e do mundo sob diferentes perspectivas.     Com apresentação de #MadeleineLacsko, o programa desmonta discursos, expõe fake news e discute os impactos das narrativas na sociedade.     Abordando temas como geopolítica, comunicação e mídia, traz uma visão aprofundada   e esclarecedora sobre o mundo atual.     Ao vivo de segunda a sexta-feira às 17h.   Apoie o jornalismo Vigilante: 10% de desconto para audiência do Narrativas  https://bit.ly/narrativasoa   Siga O Antagonista no X:  https://x.com/o_antagonista   Acompanhe O Antagonista no canal do WhatsApp. Boletins diários, conteúdos exclusivos em vídeo e muito mais.  https://whatsapp.com/channel/0029Va2SurQHLHQbI5yJN344  Leia mais em www.oantagonista.com.br | www.crusoe.com.br 

Big pharma and biotech take the earnings stage this week with reports from Eli Lilly (NYSE: LLNY) and Novo Nordisk (NYSE: NVO) leading the lineup. Will they help the industry once again outperform AI champ NVIDIA (NASDAQ: NVDA), as the industry did in 2025? Karl Thiel, Tom King, and Tim Beyers discuss: - Slow rolling chaos at FDA and its effects on drug approvals. - How to think about risk when investing in biotech. - Earnings predictions for Lilly and Novo as well as a review of results from DNA researcher Twist Bioscience (NASDAQ: TWST). Don't wait! Be sure to get to your local bookstore and pick up a copy of David's Gardner's new book — Rule Breaker Investing: How to Pick the Best Stocks of the Future and Build Lasting Wealth. It's on shelves now; get it before it's gone! Companies discussed: RGNX, LLY, NVO, TWST Host: Tim Beyers Guests: Karl Thiel, Tom King Producer: Anand Chokkavelu Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices